Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q905901> ?p ?o }
Showing triples 1 to 64 of
64
with 100 triples per page.
- Q905901 subject Q7427150.
- Q905901 subject Q8253301.
- Q905901 subject Q8515266.
- Q905901 subject Q8805811.
- Q905901 subject Q9052781.
- Q905901 abstract "Vorinostat (rINN) also known as suberanilohydroxamic acid (suberoyl+anilide+hydroxamic acid abbreviated as SAHA) is a member of a larger class of compounds that inhibit histone deacetylases (HDAC). Histone deacetylase inhibitors (HDI) have a broad spectrum of epigenetic activities.Vorinostat is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL) when the disease persists, gets worse, or comes back during or after treatment with other medicines. The compound was developed by Columbia University chemist Ronald Breslow and Memorial Sloan-Kettering researcher Paul Marks.".
- Q905901 atcPrefix "L01".
- Q905901 atcSuffix "XX38".
- Q905901 casNumber "149647-78-9".
- Q905901 chEBI "45716".
- Q905901 drugbank "DB02546".
- Q905901 fdaUniiCode "58IFB293JI".
- Q905901 iupacName "N-Hydroxy-N′-phenyloctanediamide".
- Q905901 pubchem "5311".
- Q905901 thumbnail Vorinostat.svg?width=300.
- Q905901 wikiPageExternalLink ?ligand=SHH.
- Q905901 wikiPageWikiLink Q1063862.
- Q905901 wikiPageWikiLink Q1327712.
- Q905901 wikiPageWikiLink Q15787.
- Q905901 wikiPageWikiLink Q174378.
- Q905901 wikiPageWikiLink Q178194.
- Q905901 wikiPageWikiLink Q180983.
- Q905901 wikiPageWikiLink Q186414.
- Q905901 wikiPageWikiLink Q204711.
- Q905901 wikiPageWikiLink Q2165399.
- Q905901 wikiPageWikiLink Q264118.
- Q905901 wikiPageWikiLink Q26939.
- Q905901 wikiPageWikiLink Q282142.
- Q905901 wikiPageWikiLink Q3569101.
- Q905901 wikiPageWikiLink Q3658562.
- Q905901 wikiPageWikiLink Q407693.
- Q905901 wikiPageWikiLink Q420327.
- Q905901 wikiPageWikiLink Q425894.
- Q905901 wikiPageWikiLink Q5196687.
- Q905901 wikiPageWikiLink Q7427150.
- Q905901 wikiPageWikiLink Q766195.
- Q905901 wikiPageWikiLink Q824258.
- Q905901 wikiPageWikiLink Q8253301.
- Q905901 wikiPageWikiLink Q82682.
- Q905901 wikiPageWikiLink Q8515266.
- Q905901 wikiPageWikiLink Q8805811.
- Q905901 wikiPageWikiLink Q899074.
- Q905901 wikiPageWikiLink Q901125.
- Q905901 wikiPageWikiLink Q9052781.
- Q905901 wikiPageWikiLink Q907664.
- Q905901 wikiPageWikiLink Q9368.
- Q905901 wikiPageWikiLink Q9377.
- Q905901 wikiPageWikiLink Q954625.
- Q905901 atcPrefix "L01".
- Q905901 atcSuffix "XX38".
- Q905901 casNumber "149647".
- Q905901 chebi "45716".
- Q905901 drugbank "DB02546".
- Q905901 iupacName "N-Hydroxy-N′-phenyloctanediamide".
- Q905901 pubchem "5311".
- Q905901 unii "58".
- Q905901 type ChemicalSubstance.
- Q905901 type Drug.
- Q905901 type ChemicalObject.
- Q905901 type Thing.
- Q905901 type Q8386.
- Q905901 comment "Vorinostat (rINN) also known as suberanilohydroxamic acid (suberoyl+anilide+hydroxamic acid abbreviated as SAHA) is a member of a larger class of compounds that inhibit histone deacetylases (HDAC). Histone deacetylase inhibitors (HDI) have a broad spectrum of epigenetic activities.Vorinostat is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL) when the disease persists, gets worse, or comes back during or after treatment with other medicines.".
- Q905901 label "Vorinostat".
- Q905901 depiction Vorinostat.svg.